Pfizer’s Amplyx Buy Continues Infectious Disease Deal-Making Spree

 
• By Joseph Haas
New York, July 19, 2016: Corporate lettering on the exterior of the Pfizer headquarters in Manhattan.
Pfizer makes its second major deal in the antifungal space in four years

More from Deals

More from Business